Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

NCT00929539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

496

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: JTT-130
DRUG: JTT-130 Placebo

Sponsor

Akros Pharma Inc.